Enregistrement :
8
de
10
(2023-11-22
à
2024-01-22)
Politique ou Programme
Conversations regarding the challenges that Canadian life sciences and biomanufacturing companies face in accessing capital for biomanufacturing purposes.
Conversations regarding the importance of quality assurance and accuracy in point-of-care testing, sexually transmitted infections and cancer screening, and the federal biomanufacturing strategy.